Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jui-Wen Huang

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|January 19, 2011
Screening multicomponent reactions for X-linked inhibitor of apoptosis-baculoviral inhibitor of apoptosis protein repeats domain binderIlaria Monfardini, Jui-Wen Huang, Barbara Beck, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2013
Design checkpoint kinase 2 inhibitors by pharmacophore modeling and virtual screening techniquesYen-Ling Wang, Chun-Yuan Lin, Kuei-Chung Shih, et al.
Chemical Biology & Drug Design|November 18, 2008
Binding properties of the C-terminal domain of VIAFWilliam H Bisson, Ziming Zhang, Kate Welsh, et al.
Journal of Medicinal Chemistry|July 21, 2006
Development of small-molecule cyclin D1-ablative agentsJui-Wen Huang, Chung-Wai Shiau, Jian Yang, et al.
Journal of Hepatology|March 1, 2011
Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinomaWei-Tien Tai, Ann-Lii Cheng, Chung-Wai Shiau, et al.
Journal of Hepatology|March 18, 2017
Erratum to: Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma"Wei-Tien Tai, Ann-Lii Cheng, Chung-Wai Shiau, et al.
Journal of Hepatology|January 11, 2017
Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma"Wei-Tien Tai, Ann-Lii Cheng, Chung-Wai Shiau, et al.
Cancer Research|March 1, 2005
Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgammaChung-Wai Shiau, Chih-Cheng Yang, Samuel K Kulp, et al.
Chemico-Biological Interactions|January 20, 2015
Copper-obatoclax derivative complexes mediate DNA cleavage and exhibit anti-cancer effects in hepatocellular carcinomaJung-Chen Su, Jung-Hua Chang, Jui-Wen Huang, et al.
European Journal of Medicinal Chemistry|August 9, 2012
Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activityKuen-Feng Chen, Wei-Tien Tai, Cheng-Yi Hsu, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|January 19, 2011
Screening multicomponent reactions for X-linked inhibitor of apoptosis-baculoviral inhibitor of apoptosis protein repeats domain binderIlaria Monfardini, Jui-Wen Huang, Barbara Beck, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2013
Design checkpoint kinase 2 inhibitors by pharmacophore modeling and virtual screening techniquesYen-Ling Wang, Chun-Yuan Lin, Kuei-Chung Shih, et al.
Chemical Biology & Drug Design|November 18, 2008
Binding properties of the C-terminal domain of VIAFWilliam H Bisson, Ziming Zhang, Kate Welsh, et al.
Journal of Medicinal Chemistry|July 21, 2006
Development of small-molecule cyclin D1-ablative agentsJui-Wen Huang, Chung-Wai Shiau, Jian Yang, et al.
Journal of Hepatology|March 1, 2011
Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinomaWei-Tien Tai, Ann-Lii Cheng, Chung-Wai Shiau, et al.
Journal of Hepatology|March 18, 2017
Erratum to: Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma"Wei-Tien Tai, Ann-Lii Cheng, Chung-Wai Shiau, et al.
Journal of Hepatology|January 11, 2017
Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma"Wei-Tien Tai, Ann-Lii Cheng, Chung-Wai Shiau, et al.
Cancer Research|March 1, 2005
Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgammaChung-Wai Shiau, Chih-Cheng Yang, Samuel K Kulp, et al.
Chemico-Biological Interactions|January 20, 2015
Copper-obatoclax derivative complexes mediate DNA cleavage and exhibit anti-cancer effects in hepatocellular carcinomaJung-Chen Su, Jung-Hua Chang, Jui-Wen Huang, et al.
European Journal of Medicinal Chemistry|August 9, 2012
Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activityKuen-Feng Chen, Wei-Tien Tai, Cheng-Yi Hsu, et al.
Pageof 4